DAUNOrubicin citrate liposomal

DAUNOrubicin citrate liposomal /dô′nōro̅o̅″bisin/ , an anthracycline antibiotic antineoplastic agent. ▪ INDICATIONS: It is prescribed in the treatment of advanced Kaposi’s sarcoma in HIV patients. ▪ CONTRAINDICATIONS: Known hypersensitivity to this drug prohibits its use. It is also contraindicated in pregnancy, during lactations and in patients with systemic infections or cardiac disease. ▪ ADVERSE EFFECTS: Serious adverse effects include chest pain and edema.